JP2005508892A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508892A5 JP2005508892A5 JP2003521270A JP2003521270A JP2005508892A5 JP 2005508892 A5 JP2005508892 A5 JP 2005508892A5 JP 2003521270 A JP2003521270 A JP 2003521270A JP 2003521270 A JP2003521270 A JP 2003521270A JP 2005508892 A5 JP2005508892 A5 JP 2005508892A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- addiction
- vitamin
- deficiency
- starting material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000009472 formulation Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 206010012335 Dependence Diseases 0.000 claims 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 208000012237 paracetamol poisoning Diseases 0.000 claims 1
- 108010058237 plasma protein fraction Proteins 0.000 claims 1
- 229940081857 plasma protein fraction Drugs 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101217 | 2001-08-14 | ||
| PCT/DK2002/000531 WO2003016348A2 (en) | 2001-08-14 | 2002-08-12 | A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508892A JP2005508892A (ja) | 2005-04-07 |
| JP2005508892A5 true JP2005508892A5 (enExample) | 2006-01-05 |
Family
ID=8160667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003521270A Withdrawn JP2005508892A (ja) | 2001-08-14 | 2002-08-12 | Ｇｃ−グロブリンの大規模生産のための精製方法、これにより得られる物質およびそれらの医薬用途 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1419177B1 (enExample) |
| JP (1) | JP2005508892A (enExample) |
| AT (1) | ATE393780T1 (enExample) |
| AU (1) | AU2002321012B2 (enExample) |
| CA (1) | CA2456843A1 (enExample) |
| DE (1) | DE60226327T2 (enExample) |
| DK (1) | DK1419177T3 (enExample) |
| ES (1) | ES2305272T3 (enExample) |
| WO (1) | WO2003016348A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ552680A (en) * | 2004-06-29 | 2010-03-26 | Reliance Life Sciences Pvt Ltd | Process for the preparation of virus-safe biological fluids |
| CN100354301C (zh) * | 2005-10-13 | 2007-12-12 | 南京工业大学 | 化学合成多肽的新型大规模分离制备技术 |
| US8129139B2 (en) | 2009-07-13 | 2012-03-06 | Allergan, Inc. | Process for obtaining botulinum neurotoxin |
| BR112012030530A2 (pt) * | 2010-05-18 | 2022-12-20 | Abbvie Inc | Aparelho e processo para purificação de proteínas |
| JP5860401B2 (ja) | 2010-09-03 | 2016-02-16 | 森田薬品工業株式会社 | 新規Ｇｃグロブリンガラクトース脱糖体の製造方法 |
| EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
| EP3081221B1 (en) * | 2013-12-13 | 2021-08-25 | Saisei Pharma Co., Ltd. | Pharmaceutical composition comprising a bovine colostrum enzyme processed product |
| WO2015158776A1 (en) * | 2014-04-15 | 2015-10-22 | Boehringer Ingelheim International Gmbh | Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product |
| EP3290043B1 (en) * | 2015-06-01 | 2023-03-15 | Saisei Pharma Co., Ltd. | Enzyme-treated milk product, method for producing same, composition, and product |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5177002A (en) * | 1989-11-20 | 1993-01-05 | Nobuto Yamamoto | In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor |
| JP3616392B2 (ja) * | 1990-04-11 | 2005-02-02 | ザ・ブリガム・アンド・ウイメンズ・ホスピタル・インコーポレイテッド | アクチン結合性化合物の療法的使用 |
| US6268478B1 (en) * | 1996-02-12 | 2001-07-31 | Cedars-Sinai Medical Center | Intracellular vitamin D binding protein |
-
2002
- 2002-08-12 WO PCT/DK2002/000531 patent/WO2003016348A2/en not_active Ceased
- 2002-08-12 DE DE60226327T patent/DE60226327T2/de not_active Expired - Fee Related
- 2002-08-12 AU AU2002321012A patent/AU2002321012B2/en not_active Ceased
- 2002-08-12 DK DK02754557T patent/DK1419177T3/da active
- 2002-08-12 EP EP02754557A patent/EP1419177B1/en not_active Expired - Lifetime
- 2002-08-12 ES ES02754557T patent/ES2305272T3/es not_active Expired - Lifetime
- 2002-08-12 CA CA002456843A patent/CA2456843A1/en not_active Abandoned
- 2002-08-12 JP JP2003521270A patent/JP2005508892A/ja not_active Withdrawn
- 2002-08-12 AT AT02754557T patent/ATE393780T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL378168A1 (pl) | Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków | |
| NO2014009I2 (no) | Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser | |
| AU2003293649A1 (en) | Novel xanthine derivatives, the production and the use thereof in the form of drugs | |
| IL212752A0 (en) | An molecule directed against the ??-secretase cleavage site of amyloid precursor protein, and uses thereof | |
| NO20020770L (no) | Anvendelse av monoaminoksidaseinhibitorer for fremstilling av legemidler egnet for behandling av obesitas | |
| SI1523488T1 (sl) | Novi tiofenglikozidni derivati, postopki za njihovo pripravo, zdravila, ki vsebujejo te spojine, in njihova uporaba | |
| IL213597A0 (en) | Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
| IL162669A0 (en) | Antichlinergic agents, method for producing the same and use thereof as medicaments | |
| JP2005508892A5 (enExample) | ||
| WO2003005880A3 (en) | Replikin peptides and uses thereof | |
| JP2006507484A5 (enExample) | ||
| IS8105A (is) | Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum | |
| AU2003255612A1 (en) | Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments | |
| IL197887A0 (en) | New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 | |
| EP1422240A3 (en) | Analogs of nociceptin | |
| ITRM20030259A0 (it) | Catalizzatore multistrato, procedimento per la sua preparazione e suouso per l'ossidazione parziale di idrocarburi in fase gassosa. | |
| WO2005063219A3 (en) | Ibuprofen-containing soft gelatin capsules | |
| NO20051983D0 (no) | 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav. | |
| AU2002330233A1 (en) | Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same | |
| WO2007025146A3 (en) | Balsalazide formulations and manufacture and use thereof | |
| TWI318211B (en) | Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments | |
| WO2005121328A3 (en) | Method for ameliorating an inflammatory skin condition | |
| JP2005523891A5 (enExample) | ||
| AU2003294952A1 (en) | 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same | |
| EP1411964A4 (en) | PEPTIDES MODULATING BLOOD COAGULATION AND METHODS OF USE |